Care Clinic Sp. z o.o.

At Care Clinic Sp. z o.o. in Katowice, clinical research in nervous system diseases focuses mainly on multiple sclerosis and related conditions, including primary progressive multiple sclerosis and relapsing multiple sclerosis. These studies are designed to assess new treatment options, compare therapeutic effectiveness, and better understand long-term safety in people living with chronic neurological disease.

• Testing therapies for relapsing forms of multiple sclerosis
• Evaluating treatment effectiveness in primary progressive multiple sclerosis
• Studying safety, tolerability, and delivery of ocrelizumab and ublituximab

The site’s work in this area reflects a strong interest in improving disease control and treatment convenience for patients with complex neuroimmunological disorders.

Research in skin and connective tissue diseases at this site includes studies in moderate to severe plaque psoriasis, atopic dermatitis, prurigo nodularis, vitiligo, alopecia areata, and hidradenitis suppurativa. The trials are mainly aimed at testing new therapies and improving symptom control, especially for inflammatory and autoimmune skin conditions.

• Assessing new options for plaque psoriasis and atopic dermatitis
• Evaluating treatments for itch and skin lesions in prurigo nodularis
• Studying therapies for vitiligo and alopecia areata in younger and adult patients

This dermatology portfolio highlights a broad effort to find more effective and better-tolerated approaches for chronic skin diseases.

Clinical trials in mental disorders and related brain health conditions include major depressive disorder and mild cognitive impairment due to Alzheimer’s disease, as well as Alzheimer’s disease dementia. The research is centered on evaluating adjunctive treatments for depression and exploring ways to improve symptoms and cognitive outcomes in early neurodegenerative disease.

• Testing add-on therapies for major depressive disorder
• Exploring potential symptom improvement in mild cognitive impairment and early Alzheimer’s disease
• Assessing long-term safety and patient tolerability of new psychiatric and cognitive treatments

These studies show an interest in both emotional well-being and the early stages of cognitive decline, with a focus on practical treatment benefit.

The site also conducts trials in cardiovascular diseases and nutritional and metabolic diseases, including heart failure with preserved or mildly reduced ejection fraction, broader cardiovascular disease, and overweight and obesity. The main purpose of this research is to reduce cardiovascular risk, support weight loss, and improve outcomes in patients with inflammation-related heart disease and metabolic imbalance.

• Studying therapies for heart failure and cardiovascular inflammation
• Evaluating treatments to reduce major adverse cardiovascular events
• Investigating weight-management approaches for overweight and obesity

At this research site, cardiovascular and metabolic studies are aimed at lowering long-term health risks and improving everyday disease management.

Across several therapeutic areas, Care Clinic Sp. z o.o. is involved in studies of immune system diseases that affect the nervous system, skin, muscles, and other organs. This includes research in myasthenia gravis and other autoimmune conditions, with a focus on understanding treatment response, safety, and the broader effects of immune-targeted therapies.

• Evaluating immune-focused treatments across multiple autoimmune conditions
• Studying safety and pharmacokinetics of therapies used in autoimmune diseases
• Supporting development of more precise approaches for chronic inflammatory illness

This area adds to the site’s broader profile as a center for research on long-term immune-mediated disease control.